Skip to player
Skip to main content
Search
Connect
Watch fullscreen
Like
Bookmark
Share
More
Add to Playlist
Report
Novo Going 'All-In' With Wegovy Weight Loss Pill
Bloomberg
Follow
15 hours ago
Category
🗞
News
Transcript
Display full video transcript
00:00
When it comes to the U.S. market, you've been losing share to your rival, Eli Lilly, for a couple years now.
00:05
But with this approval, you have an important first mover advantage when it comes to oral GLP-1s.
00:12
Given that you expect to start selling the pill version of Wegovi in January, whereas Eli Lilly isn't due on the market until March,
00:18
how do you plan to make the most of this head start?
00:21
Thanks very much for having me, Katie.
00:23
As they say, Christmas comes early, so I'm super excited, of course, to be here announcing the Wegovi pill.
00:31
As you say, this is really going to be super exciting for the millions of patients that have been waiting to get their hands on a GLP-1 pill.
00:41
And for the first time, we are having a pill that has an efficacy of some 17% if you take the pill regularly,
00:48
and one in three people are going to actually reduce up to 20% weight loss.
00:53
I think that data speaks for itself, and we are super excited, of course, to be the first to the market,
00:59
and we're going to go all in trying to make this a huge success.
01:04
Well, moving forward, I mean, beyond just these first few months, after Eli Lilly does have their pill on the market,
01:11
how do you plan to compete? What is your strategy there, given my understanding is that there's likely going to be no restrictions
01:18
when it comes to food, when it comes to drinks, around Lilly's version?
01:23
Yeah, so as I mentioned, there are no other phase three trials of oral GLP-1 that has shown this level of efficacy.
01:31
This means that for the first time ever, people do not have compromise
01:35
between either taking an efficacious injection or a convenient pill.
01:42
For the first time ever, you have the same efficacy of 17% in injection or a pill.
01:48
You can take it on a daily basis as a pill or a weekly injection,
01:51
and that, I think, is the key selling point with Vigo v. pill.
01:55
We also have more than 10 years of, of course, experience with regards to safety data and what have you.
02:03
That's why it's called the Vigo v. pill, which means that this pill is not only going to reduce your weight,
02:09
it also has protection for your cardiovascular systems.
02:12
So this is a phenomenal pill, second to none, I would say, and we are very ready to compete with it.
Be the first to comment
Add your comment
Recommended
3:06
|
Up next
Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound
Bloomberg
3 weeks ago
3:02
Novo Gets Approval to Sell Wegovy Obesity Pill in the US
Bloomberg
18 hours ago
1:22
Novo's Ozempic Pill Fails to Slow Alzheimer's in Studies
Bloomberg
4 weeks ago
6:29
Looking to Launch Wegovy Pill in 2026: David Moore
Bloomberg
2 months ago
3:47
Lilly, Novo to Lower Obesity Drug Prices with Trump Deal
Bloomberg
7 weeks ago
6:01
Trump Expected to Label Pot a Less Dangerous Drug
Bloomberg
2 weeks ago
1:32
Lilly, Novo Slide as Trump Touts 'Much Lower' Ozempic Price
Bloomberg
2 months ago
0:50
FDA to Reward Drugmakers That Don't 'Rip Off' the US
Bloomberg
2 months ago
3:59
FDA Has No Plans to Put Black Box Warning on Covid Vaccines, Commissioner Says
Bloomberg
1 week ago
8:47
AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs
Bloomberg
7 weeks ago
7:34
Compass Pathways Eyes FDA Approval for Psilocybin Depression Drug
Bloomberg
3 weeks ago
4:03
Novo's Ozempic Pill Fails in Alzheimer's Effort
Bloomberg
4 weeks ago
1:46
Novo Cuts Outlook Citing Lower Wegovy, Ozempic Sales
Bloomberg
7 weeks ago
5:47
FDA Pulls Warning Labels From Hormone Therapies
Bloomberg
6 weeks ago
5:53
Insilico Medicine CEO on Business Strategy
Bloomberg
2 months ago
2:25
FDA to Revisit Opioid Labeling for Chronic Pain
Bloomberg
2 months ago
1:25
FDA approves Wegovy GLP-1 pill, pushing weight-loss drugs into new era
Straight Arrow News
2 hours ago
1:34
GSK Is 'Betting Big' on the US, CEO Walmsley Says
Bloomberg
2 months ago
2:03
UnitedHealth Plummets on Report of Medicare Fraud Probe
Bloomberg
2 months ago
7:48
FDA Commissioner on Covid Vaccine Safety and Men's Health
Bloomberg
1 week ago
1:28
Moderna Posts Narrower Loss, Cost Cuts Boost Shares
Bloomberg
7 weeks ago
5:09
Portal CEO on Health Care's Expanding Funding Sources
Bloomberg
5 weeks ago
5:43
A Lot Can Go Wrong for Nvidia, Says Analyst Goldberg
Bloomberg
2 months ago
3:12
Moderna Falls As FDA Vows To Impose New Vaccine Rules
Bloomberg
3 weeks ago
1:32
Why Writing Off China Is a Huge Mistake
Bloomberg
8 hours ago
Be the first to comment